192 related articles for article (PubMed ID: 33686706)
1. Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer.
Schulz GB; Elezkurtaj S; Börding T; Schmidt EM; Elmasry M; Stief CG; Kirchner T; Karl A; Horst D
Cancer Sci; 2021 May; 112(5):1987-1996. PubMed ID: 33686706
[TBL] [Abstract][Full Text] [Related]
2. Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers.
Mittal S; Sharma A; Balaji SA; Gowda MC; Dighe RR; Kumar RV; Rangarajan A
Mol Cancer Ther; 2014 Dec; 13(12):3198-3209. PubMed ID: 25253780
[TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer.
Schmidt EM; Lamprecht S; Blaj C; Schaaf C; Krebs S; Blum H; Hermeking H; Jung A; Kirchner T; Horst D
J Exp Med; 2018 Jun; 215(6):1693-1708. PubMed ID: 29769248
[TBL] [Abstract][Full Text] [Related]
5. Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B.
Zhang Q; Wang L; Yu L; Yu Q; Xue L; Shen Z
Mol Carcinog; 2024 Jun; 63(6):1106-1116. PubMed ID: 38441297
[TBL] [Abstract][Full Text] [Related]
6. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma.
Chang HH; Lee H; Hu MK; Tsao PN; Juan HF; Huang MC; Shih YY; Wang BJ; Jeng YM; Chang CL; Huang SF; Tsay YG; Hsieh FJ; Lin KH; Hsu WM; Liao YF
Clin Cancer Res; 2010 Sep; 16(17):4411-20. PubMed ID: 20736329
[TBL] [Abstract][Full Text] [Related]
7. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
Chiang CH; Chung JG; Hsu FT
Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
[TBL] [Abstract][Full Text] [Related]
8. Laminin-integrin a6b4 interaction activates notch signaling to facilitate bladder cancer development.
Hao N; Yang D; Liu T; Liu S; Lu X; Chen L
BMC Cancer; 2022 May; 22(1):558. PubMed ID: 35585515
[TBL] [Abstract][Full Text] [Related]
9. NOTCH pathway inactivation promotes bladder cancer progression.
Maraver A; Fernandez-Marcos PJ; Cash TP; Mendez-Pertuz M; Dueñas M; Maietta P; Martinelli P; Muñoz-Martin M; Martínez-Fernández M; Cañamero M; Roncador G; Martinez-Torrecuadrada JL; Grivas D; de la Pompa JL; Valencia A; Paramio JM; Real FX; Serrano M
J Clin Invest; 2015 Feb; 125(2):824-30. PubMed ID: 25574842
[TBL] [Abstract][Full Text] [Related]
10. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
[TBL] [Abstract][Full Text] [Related]
11. Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
Hänze J; Kessel F; Di Fazio P; Hofmann R; Hegele A
Biomed Pharmacother; 2018 Oct; 106():316-325. PubMed ID: 29966976
[TBL] [Abstract][Full Text] [Related]
12. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
Zhang L; Wang CZ; Ma M; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
[TBL] [Abstract][Full Text] [Related]
13. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
Xu Z; Huang B; Zhang Q; He X; Wei H; Zhang D
J Cell Biochem; 2019 Apr; 120(4):6596-6604. PubMed ID: 30426533
[TBL] [Abstract][Full Text] [Related]
14. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
15. Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.
Ogihara K; Kikuchi E; Okazaki S; Hagiwara M; Takeda T; Matsumoto K; Kosaka T; Mikami S; Saya H; Oya M
Cancer Sci; 2019 Apr; 110(4):1431-1441. PubMed ID: 30719824
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
[TBL] [Abstract][Full Text] [Related]
17. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1.
Liu ZJ; Xiao M; Balint K; Soma A; Pinnix CC; Capobianco AJ; Velazquez OC; Herlyn M
FASEB J; 2006 May; 20(7):1009-11. PubMed ID: 16571776
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.
Kassouf W; Dinney CP; Brown G; McConkey DJ; Diehl AJ; Bar-Eli M; Adam L
Cancer Res; 2005 Nov; 65(22):10524-35. PubMed ID: 16288045
[TBL] [Abstract][Full Text] [Related]
20. Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.
Ahmed AA; Robinson T; Palande M; Escara-Wilke J; Dai J; Keller ET
J Cell Biochem; 2019 Oct; 120(10):16946-16955. PubMed ID: 31099068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
